488 related articles for article (PubMed ID: 30719129)
1. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
Cai C; Wang W; Tu Z
J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
[No Abstract] [Full Text] [Related]
2. Combined screening analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Cao J; Zhang R; Zhang Y; Wang Y
J Gastrointest Oncol; 2022 Feb; 13(1):311-325. PubMed ID: 35284134
[TBL] [Abstract][Full Text] [Related]
3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer.
Liu J; Li H; Sun L; Wang Z; Xing C; Yuan Y
Cancer Cell Int; 2017; 17():75. PubMed ID: 28794688
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
7. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
8. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
9. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation biomarkers for hepatocellular carcinoma.
Fan G; Tu Y; Chen C; Sun H; Wan C; Cai X
Cancer Cell Int; 2018; 18():140. PubMed ID: 30245591
[TBL] [Abstract][Full Text] [Related]
11. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
12. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of
Bai L; Ren Y; Cui T
J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
[TBL] [Abstract][Full Text] [Related]
14. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
16. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
17. Identification of abnormally methylated-differentially expressed genes and pathways in osteoarthritis: a comprehensive bioinformatic study.
Zheng L; Chen W; Xian G; Pan B; Ye Y; Gu M; Ma Y; Zhang Z; Sheng P
Clin Rheumatol; 2021 Aug; 40(8):3247-3256. PubMed ID: 33420869
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.
Wu M; Liu Z; Zhang A; Li N
Medicine (Baltimore); 2019 Feb; 98(5):e14287. PubMed ID: 30702595
[TBL] [Abstract][Full Text] [Related]
19. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
PeerJ; 2019; 7():e7408. PubMed ID: 31392101
[TBL] [Abstract][Full Text] [Related]
20. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
